文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

13价肺炎球菌结合疫苗后幼童中候选广谱结合疫苗血清型的动态变化

Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines.
PubMed 文献 · Emerg Infect Dis · 2021-01-01

研究在PCV13后期(2015-2017)和早期PCV(2009-2011)对比了2岁以下儿童中非PCV13额外PCV20血清型(VT20-13)与其他非VT20血清型的动态。采用前瞻性人群多面监测,涵盖健康携带、下呼吸道感染、非下呼吸道感染、结膜炎、中耳炎和侵袭性肺炎球菌病分离株。结果显示VT20-13在中耳炎、侵袭性肺炎球菌病和下呼吸道感染携带中不成比例增加,且更常对 antimicrobial 不敏感。

要点

  • PCV13实施后VT20-13在中耳炎、IPD和下呼吸道感染携带中不成比例增加。
  • VT20-13血清型较非VT20血清型更常对 antimicrobial 不敏感。
  • VT20-13在呼吸道感染和IPD中的增加提示其疾病潜力高于其他非VT20血清型。

核心结论

  • PCV13实施后VT20-13在中耳炎、IPD和下呼吸道感染携带中不成比例增加,提示其疾病潜力高于其他非VT20血清型。

研究设计与样本

  • 前瞻性人群多面监测,纳入2岁以下儿童,比较PCV13后期(2015-2017)与早期PCV(2009-2011)期间分离株。

主要发现

  • VT20-13/non-VT20患病率比值范围为0.26-1.40。
  • VT20-13血清型较非VT20血清型更常对 antimicrobial 不敏感。

临床怎么用

  • 监测VT20-13血清型在儿童呼吸道感染和IPD中的动态,关注其 antimicrobial 不敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

After worldwide implementation of 10-valent and 13-valent pneumococcal conjugate vaccines (PCV10/PCV13), a 20-valent PCV (PCV20) was developed. We assessed dynamics of non-PCV13 additional PCV20 serotypes (VT20-13), compared with all other non-VT20 serotypes, in children <2 years of age in late PCV13 (2015-2017) and early PCV (2009-2011) periods. Our prospective population-based multifaceted surveillance included isolates from carriage in healthy children, children requiring chest radiography for lower respiratory tract infections (LRTIs), and children with non-LRTI illness, as well as isolates from acute conjunctivitis, otitis media (OM), and invasive pneumococcal disease (IPD). After PCV13 implementation, VT20-13 increased disproportionally in OM, IPD, and carriage in LRTI. VT20-13/non-VT20 prevalence ratio range was 0.26-1.40. VT20-13 serotypes were more frequently antimicrobial-nonsusceptible than non-VT20 serotypes. The disproportionate increase of VT20-13 in respiratory infections and IPD points to their higher disease potential compared with all other non-VT20 as a group.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ben-Shimol S, Givon-Lavi N, Kotler L, et al. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines. Emerg Infect Dis. 2021. PMID: 33350916. doi:10.3201/eid2701.201178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。